Monensin (MOS) - Medicating ingredient brochure

Revised November 2022

Broiler chickens

Approved for use in meal or pellet feed

Claim 1

As an aid in the prevention of coccidiosis caused by Eimeria necatrix, E. tenella, E. acervulina, E. brunetti, E. mitis, and E. maxima in broiler chickens.

Level of medicating ingredient in a complete feed

100 mg/kg (0.01%) of monensin in the complete feed.

Directions for use in a complete feed

Feed this medicated feed continuously as sole ration to broiler chickens.

Warning

1. No withdrawal period is required when treated at the recommended dose of 100 mg monensin per kg (0.01%) of complete feed.
2. Do not feed to replacement or laying chickens.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not use this medicated feed for treatment of outbreaks of Coccidiosis.
2. Do not allow dogs, horses, other equines, or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
3. This feed contains monensin: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances. Animals including birds should not be treated with products containing tiamulin while receiving, or for at least 7 days before or after receiving, feed containing monensin. Severe growth depression or death may occur.
4. May be used in feeds containing the following pellet binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)

Accepted Compatibilities

Monensin is compatible in single combination with any of the following drugs. In cases where there are differences in withdrawal time for the compatible medicating ingredients, the longer withdrawal time is the one that must be used, and is the only one that is to appear on the label of the finished feed. For details, refer to the MIB as indicated.

Growing turkeys

Approved for use in meal or pellet feed

Claim 1

As an aid in the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallapavonis in growing turkeys.

Level of medicating ingredient in a complete feed

100 mg/kg (0.01%) of monensin in the complete feed.

Directions for use in a complete feed

Feed this medicated feed continuously as the sole ration to growing turkeys.

Warning

1. No withdrawal period is required when treated at the recommended dose of 100 mg monensin per kg (0.01%) of complete feed.
2. Do not feed to replacement, laying or breeding turkeys.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not use this medicated feed for treatment of outbreaks of coccidiosis.
2. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestions of monensin by these species has been fatal.
3. This feed contains monensin: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances. Avoid simultaneous administration of monensin and sulphonamides to turkeys as instances of possible intoxication have been reported. Animals including birds should not be treated with products containing tiamulin while receiving, or for at least 7 days before or after receiving, feed containing monensin. Severe growth depression or death may occur.
4. Some species of turkey coccidia may be monensin tolerant.
5. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)

Accepted Compatibilities

Nil

Beef cattle

Approved for use in meal or pellet feed
Approved for use in thixotropic liquid supplements

Claim 1

For improved feed efficiency in beef cattle (steers and heifers) fed in confinement for slaughter.

Level of medicating ingredient in a complete feed

Choose one of the feeding programs provided below:

Option 1: From start to market weight:

33 mg/kg to 48 mg/kg (0.0033% to 0.0048%) of monensin in the complete diet.

Option 2: Feeding program approved with the use of Monensin Premix only

1. Introductory period of 28 days:
   11 mg/kg (0.0011%) of monensin in the complete diet; followed by
2. Remainder of feeding period to market weight:
   33 mg/kg (0.0033%) of monensin in the complete diet

Note (not required to appear on medicated feed labels)

• Complete diet refers to the complete feed plus the roughage (i.e., the total diet) and must be corrected to a 100% dry matter basis.

Directions for use

At a level in supplements, premixes, and complete feeds so that when used as directed, the approved level of drug will be supplied.

Thoroughly mix the supplements and premixes in the total daily diet or in complete feed (grain portion of the ration) before use. Do not feed undiluted.

Medicated supplements and premixes fed as a percentage (%) of total diet dry matter:

Mixing medicated supplements or premixes as a percentage (%) of total diet dry matter is recommended. The following calculation can be used to assist in determining the amount of monensin required per kg of supplement/premix dry matter to meet the approved level of drug in the total diet dry matter:

mg monensin/kg supplement or premix dry matter = [approved drug level (mg/kg total diet dry matter) ÷ (% inclusion of supplement or premix in diet on a 100% dry matter basis)] × 100

Medicated supplements and premixes fed as a fixed amount on a per head per day basis:

It may sometimes be preferable to mix the medicated supplement/premix in the complete feed or total diet as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Medicated complete feeds:

Medicated complete feeds are often fed separately from the forage part of the ration as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Warning

1. Do not supplement monensin from other sources (e.g., other feedstuffs containing monensin or slow release devices containing monensin).
2. No withdrawal period or milk withholding time is required when treated up to 48 mg monensin per kg (0.0048%) of complete diet.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not exceed recommended levels as reduced average daily gains may result.
2. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
3. Feed only to beef cattle (steers and heifers) intended for slaughter and maintained under confinement.
4. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)
5. Do not use thixotropic supplements after eight weeks of storage (Westway Feed Products) (required on thixotropic liquid supplement labels only)

Accepted compatibilities

Monensin is compatible in single combination with any of the following drugs. In cases where there are differences in withdrawal time for the compatible medicating ingredients, the longer withdrawal time is the one that must be used, and is the only one that is to appear on the label of the finished feed. For details, refer to the MIB as indicated.

Monensin is compatible with multiple drugs in the following combination. In cases where there are differences in withdrawal time for the compatible medicating ingredients, the longer withdrawal time is the one that must be used, and is the only one that is to appear on the label of the finished feed. For details, refer to the MIB as indicated.

Cattle

Approved for use in meal or pellet feed
Approved for use in thixotropic liquid supplements

Claim 1

As an aid in the prevention of coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle.

Level of medicating ingredient in a complete feed

22 mg/kg (0.0022%) of monensin in the complete diet.

Directions for use

At a level in supplements, premixes, and complete feeds so that when used as directed, the approved level of drug will be supplied. Thoroughly mix supplements and premixes in the total daily diet or in complete feed (grain portion of the ration) before use.

Do not feed undiluted.

Medicated supplements and premixes fed as a percentage (%) of total diet dry matter:

Mixing medicated supplements or premixes as a percentage (%) of total diet dry matter is recommended. The following calculation can be used to assist in determining the amount of monensin required per kg of supplement/premix dry matter to meet the approved level of drug in the total diet dry matter:

mg monensin/kg supplement or premix dry matter = [approved drug level (mg/kg total diet dry matter) ÷ (% inclusion of supplement or premix in diet on a 100% dry matter basis)] × 100

Medicated supplements and premixes fed as a fixed amount on a per head per day basis:

It may sometimes be preferable to mix the medicated supplement/premix in the complete feed or total diet as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Medicated complete feeds:

Medicated complete feeds are often fed separately from the forage part of the ration as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Warning

1. Do not supplement monensin from other sources (e.g., other feedstuffs containing monensin or slow release devices containing monensin).
2. No withdrawal period or milk withholding time is required when treated at the recommended dose of 22 mg monensin per kg (0.0022%) of complete diet.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not exceed recommended levels as reduced average daily gains may result.
2. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
3. Do not use monensin-medicated feed for the treatment of outbreaks of coccidiosis.
4. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)
5. Do not use thixotropic supplements after eight weeks of storage. (Westway Feed Products) (required on thixotropic liquid supplement labels only)

Accepted Compatibilities

Monensin is compatible in single combination with any of the following drugs. In cases where there are differences in withdrawal time for the compatible medicating ingredients, the longer withdrawal time is the one that must be used, and is the only one that is to appear on the label of the finished feed. For details, refer to the MIB as indicated.

Pasture cattle

Approved for use in meal or pellet feed

Claim 1

For increased rate of weight gain in growing cattle on pasture (slaughter, stocker and feeder cattle, and beef and dairy replacement heifers) of greater than 180 kg (400 lb) body weight.

Level of medicating ingredient in a complete feed

200 mg of monensin per head per day.

Directions for use

Hand feed continuously a minimum of 0.5 kg of medicated supplement per head per day, to supply 200 mg of monensin per head per day. The medicated supplement must be hand fed from the beginning to the end of the pasture season.

Warning

1. Do not supplement monensin from other sources (e.g., other feed stuffs containing monensin or slow release devices containing monensin).
2. No withdrawal period or milk withholding time is required when treated at the recommended level of 200 mg monensin per head per day.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not exceed recommended levels as reduced average daily gains may result.
2. Do not allow dogs, horses or other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
3. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)

Accepted compatibilities

Nil

Lactating dairy cows

Approved for use in meal or pellet feed
Approved for use in thixotropic liquid supplements

Claim 1

For reduction of milk fat percentage in lactating dairy cows.

Level of medicating ingredient in a complete feed

16 mg/kg to 24 mg/kg (0.0016% to 0.0024%) of monensin in the complete diet.

Directions for use

At a level in supplements, premixes, and complete feeds so that when used as directed, the approved level of drug will be supplied.

Thoroughly mix supplements and premixes in the total daily diet or in the complete feed (grain portion of the ration) before use. Do not feed undiluted.

Medicated supplements and premixes fed as a percentage (%) of total diet dry matter:

Mixing medicated supplements or premixes as a percentage (%) of total diet dry matter is recommended. The following calculation can be used to assist in determining the amount of monensin required per kg of supplement/premix dry matter to meet the approved level of drug in the total diet dry matter:

mg monensin/kg of supplement or premix dry matter = [approved drug level (mg/kg total diet dry matter) ÷ (% inclusion of supplement or premix in diet on a 100% dry matter basis)] × 100

Medicated supplements and premixes fed as a fixed amount on a per head per day basis:

It may sometimes be preferable to mix the medicated supplement/premix in the complete feed or total diet as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Medicated complete feeds:

Medicated complete feeds are often fed separately from the forage part of the ration as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Warning

1. Do not supplement more than 16 mg of monensin per kg of complete diet to dairy cows in herds administered slow release devices containing monensin.
2. No withdrawal period or milk withholding time is required when treated at up to 24 mg of monensin (0.0024%) per kg in the complete diet.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
2. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)
3. Do not use thixotropic supplements after eight weeks of storage. (Westway Feed Products) (required on thixotropic liquid supplement labels only)
4. The 24 mg/kg (or 24 g/tonne of complete diet) monensin treatment in primiparous cows may result in the increased incidence of udder edema and increased number of inseminations per full term conception.
5. The continuous use of monensin in dairy cows may be associated with increased rates of twinning and stillbirths, and heavier birth weights for heifer calves.

Claim 2

For improving feed efficiency of milk protein production in lactating dairy cows.

Level of medicating ingredient in a complete feed

16 mg/kg to 24 mg/kg (0.0016% to 0.0024%) of monensin in the complete diet.

Directions for use

At a level in supplements, premixes, and complete feeds so that when used as directed, the approved level of drug will be supplied.

Thoroughly mix supplements and premixes in the total daily diet or in complete feed (grain portion of the ration) before use. Do not feed undiluted.

Medicated supplements and premixes fed as a percentage (%) of total diet dry matter:

Mixing medicated supplements or premixes as a percentage (%) of total diet dry matter is recommended. The following calculation can be used to assist in determining the amount of monensin required per kg of supplement/premix dry matter to meet the approved level of drug in the total diet dry matter:

mg monensin/kg of supplement or premix dry matter = [approved drug level (mg/kg total diet dry matter) ÷ (% inclusion of supplement or premix in diet on a 100% dry matter basis)] × 100

Medicated supplements and premixes fed as a fixed amount on a per head per day basis:

It may sometimes be preferable to mix the medicated supplement/premix in the complete feed or total diet as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Medicated complete feeds:

Medicated complete feeds are often fed separately from the forage part of the ration as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Warning

1. Do not supplement more than 16 mg of monensin per kg of complete diet to dairy cows in herds administered slow release devices containing monensin.
2. No withdrawal period or milk withholding time is required when treated at up to 24 mg of monensin (0.0024%) per kg in the complete diet.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
2. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)
3. Do not use thixotropic supplements after eight weeks of storage. (Westway Feed Products) (required on thixotropic liquid supplement labels only)
4. The 24 mg/kg (or 24 g/tonne of complete diet) monensin treatment in primiparous cows may result in the increased incidence of udder edema and increased number of inseminations per full term conception.
5. The continuous use of monensin in dairy cows may be associated with increased rates of twinning and stillbirths, and heavier birth weights for heifer calves.

Accepted Compatibilities

Nil

Dry and lactating dairy cows

Approved for use in meal or pellet feed
Approved for use in thixotropic liquid supplements

Claim 1

For minimizing loss of body condition during lactation in dairy cows.

Level of medicating ingredient in a complete feed

8 mg/kg to 24 mg/kg (0.0008% to 0.0024%) of monensin in the complete diet.

Directions for use

At a level in supplements, premixes, and complete feeds so that when used as directed, the approved level of drug will be supplied.

Thoroughly mix supplements and premixes in the total daily diet or in complete feed (grain portion of the ration) before use. Feed continuously during the dry and lactating periods. Do not feed undiluted.

Medicated supplements and premixes fed as a percentage (%) of total diet dry matter:

Mixing medicated supplements or premixes a percentage (%) of total diet dry matter is recommended. The following calculation can be used to assist in determining the amount of monensin required per kg of supplement/premix dry matter to meet the approved level of drug in the total diet dry matter:

mg monensin/kg of supplement or premix dry matter = [approved drug level (mg/kg total diet dry matter) ÷ (% inclusion of supplement or premix in diet on a 100% dry matter basis)] × 100

Medicated supplements and premixes fed as a fixed amount on a per head per day basis:

It may sometimes be preferable to mix the medicated supplement/premix in the complete feed or total diet as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Medicated complete feeds:

Medicated complete feeds are often fed separately from the forage part of the ration as a fixed amount on a per head per day basis. The approved levels of monensin must be converted to mg/head/day to accommodate this type of feeding. To do this, the following calculation is used:

mg monensin/head/day = weight of animal (kg) × dry matter intake (as a % of body weight) × approved drug level (mg/kg total diet dry matter).

Note that feed labels will be required to state both the body weight of the cattle being fed as well as their dry matter (DM) intake.

Warning

1. Do not supplement more than 16 mg of monensin per kg of complete diet to dairy cows in herds administered slow release devices containing monensin.
2. No withdrawal period or milk withholding time is required when treated at up to 24 mg of monensin (0.0024%) per kg in the complete diet.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
2. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)
3. Do not use thixotropic supplements after eight weeks of storage. (Westway Feed Products) (required on thixotropic liquid supplement labels only)
4. The 24 mg/kg (or 24 g/tonne of complete diet) monensin treatment in primiparous cows may result in the increased incidence of udder edema and increased number of inseminations per full term conception.
5. The continuous use of monensin in dairy cows may be associated with increased rates of twinning and stillbirths, and heavier birth weights for heifer calves.

Accepted compatibilities

Nil

Sheep

Approved for use in meal or pellet feed

Claim 1

For the prevention of coccidiosis associated with pathogenic Eimeria spp. in sheep.

Level of medicating ingredient in a complete feed

11 mg/kg to 22 mg/kg (0.0011% to 0.0022%) of monensin in the complete diet.

Directions for use

At a level in supplements, premixes, and complete feeds so that when used as directed, the approved level of drug will be supplied.

Thoroughly mix in supplements, premixes or in complete feeds before use. Do not feed undiluted.

Feed this medicated feed continuously as sole ration to sheep.

Warning

1. No withdrawal period is required for sheep when treated at the recommended dose of 11 to 22 mg/kg (0.0011 to 0.0022%) of the complete diet.
2. Do not use in lactating dairy sheep producing milk for food
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only)
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not exceed recommended use levels as reduced average daily gains may result.
2. Do not use in lactating ewes.
3. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
4. Do not use monensin-medicated feeds for the treatment of outbreaks of coccidiosis.
5. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)
6. Feeding monensin undiluted or mixing errors resulting in high concentrations of monensin could cause reduced feed intake, poor growth, diarrhea and death of sheep.
7. Response to monensin is unlikely if medicated feed intake is insufficient

Accepted compatibilities

Nil

Goats

Approved for use in meal or pellet feed

Claim 1

For the prevention of coccidiosis associated with Eimeria crandallis, E. christenseni, and E. ninakohlyakimovae in goats.

Level of medicating ingredient in a complete feed

11 mg/kg to 22 mg/kg (0.0011% to 0.0022%) of monensin in the complete diet.

Directions for use

At a level in supplements, premixes, and complete feeds so that when used as directed, the approved level of drug will be supplied.

Thoroughly mix in supplements, premixes or in complete feeds before use. Do not feed undiluted.

Feed this medicated feed continuously as sole ration to goats.

Warning

1. No withdrawal period is required for goats when treated at the recommended dose of 11 to 22 mg/kg (0.0011 to 0.0022%) of the complete diet.
2. Do not use in lactating dairy goats producing milk for food.
3. When mixing and handling monensin, avoid inhalation, oral exposure and direct contact with skin or eyes. Use protective clothing, impervious gloves and dust mask. Operators should wash thoroughly with soap and water after handling (required on premix and supplement labels only).
4. Keep out of reach of children (required on premix and supplement labels only)

Caution

1. Do not exceed recommended use levels as reduced average daily gains may result.
2. Do not use in lactating goats.
3. Do not allow dogs, horses, other equines or guinea fowl access to formulations containing monensin. Ingestion of monensin by these species has been fatal.
4. Do not use monensin-medicated feeds for the treatment of outbreaks of coccidiosis.
5. May be used in feeds containing the following pellet-binding agents: bentonite (2%), attapulgite (2%), kaolin (2.5%), lignin sulfonate (4%), carboxymethylcellulose (0.1%), or Agri-Colloid (required on premix and supplement labels only)
6. Feeding monensin undiluted or mixing errors resulting in high concentrations of monensin could cause reduced feed intake, poor growth, diarrhea and death of goats.
7. Response to monensin is unlikely if medicated feed intake is insufficient.

Accepted compatibilities

Nil